Growth Metrics

Medinotec (MDNC) Change in Accured Expenses (2022 - 2023)

Medinotec posted quarterly Change in Accured Expenses of $7797.0 for Q4 2023, down 44.14% year-on-year from $13957.0 in Q4 2022, and down 2.17% on a QoQ basis from $7970.0 in Q3 2023.

Medinotec (MDNC) has 2 years of Change in Accured Expenses data on file, last reported at $7797.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -654.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 703.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -512.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -347.10 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 21.07 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 145.10 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -250.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 74.30 Mn
10 Medinotec - - 854,557.00 -

Historic Data

Download Data 🔒
DateValue
Nov 30, 2023 7,797.00
Nov 30, 2023 7,797.00
Aug 31, 2023 7,970.00
Aug 31, 2023 7,970.00
Nov 30, 2022 13,957.00
Nov 30, 2022 13,957.00
Aug 31, 2022 8,800.00
Aug 31, 2022 8,800.00